A pharmacovigilance team is investigating a potential link between a newly introduced fluoroquinolone antibiotic and the development of Achilles tendon rupture. The investigators access a large, national commercial insurance database containing continuous enrollment and claims data. They first identify 850 patients in the database who had a diagnostic code for Achilles tendon rupture between 2020 and 2025. Next, they select 3,400 patients from the same database who did not experience this injury, matching them to the initial group by age, sex, and geographic region. Finally, the investigators review the historical pharmacy claims data for all 4,250 selected individuals to determine whether they were prescribed the fluoroquinolone in the 6 months prior to the index date of tendon rupture or the equivalent matched date. Based on the methodology described, which of the following is the most appropriate primary measure of association to calculate for this investigation?
- Odds ratioCevap
- BRelative risk
- CHazard ratio
- DPrevalence ratio
- EIncidence rate ratio